MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES: A PROMISING THERAPEUTIC APPROACH FOR AGE-RELATED MACULAR DEGENERATION | ||||
| Assiut Veterinary Medical Journal | ||||
| Article 36, Volume 71, Issue 186, July 2025, Page 435-446 PDF (708.34 K) | ||||
| Document Type: Review article | ||||
| DOI: 10.21608/avmj.2025.356416.1571 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
RANA ABDELKHALEK  1; MOHAMED M. BAHR1; ISLAM ELGOHARY2; MARWA A. FOULY3; ASHRAF SHAMAA1
| ||||
| 1Department of Surgery, Anesthesiology, and Radiology, Faculty of Veterinary Medicine, Cairo University, Giza, Egypt. | ||||
| 2Department of Pathology, Animal Health Research Institute, Agricultural Research Centre, Giza, Egypt | ||||
| 3Research Institute of Ophthalmology, Giza, Egypt. | ||||
| Abstract | ||||
Age-related macular degeneration (AMD) is a progressive retinal disorder that leads to vision loss, mainly because the retinal pigment epithelium (RPE) and photoreceptors break down. AMD pathophysiology involves complex mechanisms, such as oxidative stress, severe inflammation, and cellular degeneration, leading to drusen and lipofuscin formation. And current treatments, such as retinal laser therapy, photodynamic therapy, and even anti-vascular endothelial growth factor, showed high limitations, especially for dry AMD. So, this review revealed the systematic potential effect of mesenchymal stem cell-derived exosomes (MSC-Exos) as a novel treatment for AMD. MSC-Exos influence gene expression, remodel the extracellular matrix, and deliver growth factors. These characteristics offer a more effective treatment for AMD. | ||||
| Keywords | ||||
| Age-related-macular-degeneration; Exosomes; retinal-degeneration; immunomodulation | ||||
|
Statistics Article View: 89 PDF Download: 59 |
||||
